These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 22982443)
1. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1. Liu S; Tetzlaff MT; Cui R; Xu X Am J Pathol; 2012 Nov; 181(5):1823-35. PubMed ID: 22982443 [TBL] [Abstract][Full Text] [Related]
2. miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3. Liu L; Qiu M; Tan G; Liang Z; Qin Y; Chen L; Chen H; Liu J J Transl Med; 2014 Nov; 12():305. PubMed ID: 25367080 [TBL] [Abstract][Full Text] [Related]
3. miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment. Liu S; Tetzlaff MT; Wang T; Yang R; Xie L; Zhang G; Krepler C; Xiao M; Beqiri M; Xu W; Karakousis G; Schuchter L; Amaravadi RK; Xu W; Wei Z; Herlyn M; Yao Y; Zhang L; Wang Y; Zhang L; Xu X Pigment Cell Melanoma Res; 2015 Jul; 28(4):431-41. PubMed ID: 25903073 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro. Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma. Liu S; Kumar SM; Lu H; Liu A; Yang R; Pushparajan A; Guo W; Xu X J Pathol; 2012 Jan; 226(1):61-72. PubMed ID: 22131135 [TBL] [Abstract][Full Text] [Related]
6. Loss of microRNA-205 expression is associated with melanoma progression. Liu S; Tetzlaff MT; Liu A; Liegl-Atzwanger B; Guo J; Xu X Lab Invest; 2012 Jul; 92(7):1084-96. PubMed ID: 22525428 [TBL] [Abstract][Full Text] [Related]
7. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1. Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of intratumoral expression of miR-205, miR-200c and miR-125b in primary human cutaneous melanomas predicts shorter survival. Sánchez-Sendra B; Martinez-Ciarpaglini C; González-Muñoz JF; Murgui A; Terrádez L; Monteagudo C Sci Rep; 2018 Nov; 8(1):17076. PubMed ID: 30459436 [TBL] [Abstract][Full Text] [Related]
9. Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression. van Kempen LC; van den Hurk K; Lazar V; Michiels S; Winnepenninckx V; Stas M; Spatz A; van den Oord JJ Virchows Arch; 2012 Oct; 461(4):441-8. PubMed ID: 22956368 [TBL] [Abstract][Full Text] [Related]
10. miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1. Yu J; Lu Y; Cui D; Li E; Zhu Y; Zhao Y; Zhao F; Xia S Oncol Rep; 2014 Feb; 31(2):910-8. PubMed ID: 24317363 [TBL] [Abstract][Full Text] [Related]
11. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis. Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305 [TBL] [Abstract][Full Text] [Related]
12. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance. Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of Bmi-1 suppresses epithelial‑mesenchymal transition in melanoma. Liu Y; Chu Z; Li Q; Peng B; Xu S; Lian CG; Geng S Oncol Rep; 2017 Jan; 37(1):139-146. PubMed ID: 27878257 [TBL] [Abstract][Full Text] [Related]
14. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression. Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750 [TBL] [Abstract][Full Text] [Related]
15. MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process. Wang HY; Liu YN; Wu SG; Hsu CL; Chang TH; Tsai MF; Lin YT; Shih JY Cancer Biomark; 2020; 28(3):351-363. PubMed ID: 32417760 [TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma. Long J; Menggen Q; Wuren Q; Shi Q; Pi X Med Sci Monit; 2018 Mar; 24():1547-1559. PubMed ID: 29543785 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. Xu Y; Brenn T; Brown ER; Doherty V; Melton DW Br J Cancer; 2012 Jan; 106(3):553-61. PubMed ID: 22223089 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma. Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W Melanoma Res; 2019 Dec; 29(6):569-581. PubMed ID: 30889053 [TBL] [Abstract][Full Text] [Related]
19. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Ceppi P; Mudduluru G; Kumarswamy R; Rapa I; Scagliotti GV; Papotti M; Allgayer H Mol Cancer Res; 2010 Sep; 8(9):1207-16. PubMed ID: 20696752 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-148b Inhibits the Malignant Biological Behavior of Melanoma by Reducing Sirtuin 7 Expression Levels. Sun R; Guo M; Fan X; Meng Q; Yuan D; Yang X; Yan K; Deng H Biomed Res Int; 2020; 2020():9568976. PubMed ID: 33274232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]